Kristin M. Tolle

Kristin M. Tolle

Auto-generated profile, based on publicly available information

Kristin M. Tolle

University of Arizona

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
CLCynthia Lerouge
Cynthia Lerouge
JMJiao Ma
Jiao Ma
SSSweta Sneha
Sweta Sneha
KTKristin Tolle
Kristin Tolle

18 July 2011 in Proceedings of the IEEE
Verified
Journal Article
Closed access
KTKristin M. Tolle
Kristin M. Tolle
DTD. Stewart W. Tansley
D. Stewart W. Tansley
AHAnthony J. G. Hey
Anthony J. G. Hey
We are now seeing governments and funding agencies looking at ways to increase the value and pace of scientific research through increased or open access to both data and publications. In this point of view article, we wish to look at another aspect of these twin revolutions, namely, how to enable developers, designers and researchers to build intuitive,multimodal, user-centric, scientific applications that can aid and enable scientific research.

1 January 2000 in Journal of the American Society for Information Science
Verified
Journal Article
Closed access
PDF file
KTKristin M. Tolle
Kristin M. Tolle
HCHsinchun Chen
Hsinchun Chen

1 July 1997 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
HCHsiao-Hui Chow
Hsiao-Hui Chow
KTKristin M. Tolle
Kristin M. Tolle
DRDenise J. Roe
Denise J. Roe
VEVictor Elsberry
Victor Elsberry
HCHsinchun Chen
Hsinchun Chen
This research examined the applicability of using a neural network approach to analyze population pharmacokinetic data. Such data were collected retrospectively from pediatric patients who had received tobramycin for the treatment of bacterial infection. The information collected included patient-related demographic variables (age, weight, gender, and other underlying illness), the individual's dosing regimens (dose and dosing interval), time of blood drawn, and the resulting tobramycin concentration. Neural networks were trained with this information to capture the relationships between the plasma tobramycin levels and the following factors: patient-related demographic factors, dosing regimens, and time of blood drawn. The data were also analyzed using a standard population pharmacokinetic modeling program, NON-MEM. The observed vs predicted concentration relationships obtained from the neural network approach were similar to those from NONMEM. The residuals of the predictions from neural network analyses showed a positive correlation with that from NONMEM. Average absolute errors were 33.9 and 37.3% for neural networks and 39.9% for NONMEM. Average prediction errors were found to be 2.59 and -5.01% for neural networks and 17.7% for NONMEM. We concluded that neural networks were capable of capturing the relationships between plasma drug levels and patient-related prognostic factors from routinely collected sparse within-patient pharmacokinetic data. Neural networks can therefore be considered to have potential to become a useful analytical tool for population pharmacokinetic data analysis.

1 December 2000 in Decision Support Systems
Verified
Journal Article
Closed access
KTKristin M. Tolle
Kristin M. Tolle
HCHsinchun Chen
Hsinchun Chen
HCHsiao-Hui Chow
Hsiao-Hui Chow

1 January 2000
Verified
Book Chapter
Closed access
PDF file
KTKristin M. Tolle
Kristin M. Tolle
HCHsinchun Chen
Hsinchun Chen